TransMedics Group, Inc. (TMDX) shares are experiencing a notable uptick today, driven by positive sentiment from Wall Street analysts and investor optimism. The stock has gained traction following a favorable consensus recommendation from brokerage firms, which currently stands at 1.8, indicating an "Outperform" status. Analysts have set an average one-year price target of $123.00, suggesting a significant upside potential from the current trading levels. This bullish outlook is further supported by GuruFocus estimates, which project a GF Value of $277.98 for TMDX, implying a substantial upside of over 227% from the current price.
The current price of TransMedics Group, Inc. (TMDX) is $84.77, reflecting a 5.16% increase from its previous close of $80.61. The stock opened at $81.55 and has seen a 3.95% rise from the opening price.